Shanghai Shyndec Pharmaceutical Co., Ltd. Class ASSE: 600420

Announcement on Voluntary Information Disclosure of Wholly-owned Subsidiary's Drug Passing Consistency Evaluation for Generic Drugs

· Issued by Shanghai Shyndec Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Information Disclosure of Wholly-owned Subsidiary's Drug Passing Consistency Evaluation for Generic Drugs

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment